Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47,386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of remimazolam besylate in bronchoscopy for adults: A multicenter, randomized, double-blind, positive-controlled clinical study.
Zhou YY, Yang ST, Duan KM, Bai ZH, Feng YF, Guo QL, Cheng ZG, Wu H, Shangguan WN, Wu XM, Wang CH, Chai XQ, Xu GH, Liu CM, Zhao GF, Chen C, Gao BA, Li LE, Zhang M, Ouyang W, Wang SY. Zhou YY, et al. Among authors: wu h, wu xm. Front Pharmacol. 2022 Oct 13;13:1005367. doi: 10.3389/fphar.2022.1005367. eCollection 2022. Front Pharmacol. 2022. PMID: 36313321 Free PMC article.
Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial.
Lin J, Wang Q, Zhong D, Zhang J, Yuan T, Wu H, Li B, Li S, Xie X, An D, Deng Y, Xian S, Xiong X, Yao K. Lin J, et al. Among authors: wu h. Front Pharmacol. 2023 Jul 10;14:1225529. doi: 10.3389/fphar.2023.1225529. eCollection 2023. Front Pharmacol. 2023. PMID: 37492087 Free PMC article.
Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition).
Zhao B, Zhou X, Zheng P, Zhang B, Feng X, Chen J, Cai L, Chen Y, He L, Su J, Cheng S, Zeng Y, Li G, Ji B, Wu J, Feng W, Liu M, Jin Y, Liu T, Mo X, Wu J, Wu H, Zhang H, Zheng Z, Zheng Z, Sun J, Li Y; Guangdong Pharmaceutical Association, Hematology Group of Rare Disease Expert Committee of Guangdong Pharmaceutical Association. Zhao B, et al. Among authors: wu h, wu j. Front Pharmacol. 2024 Nov 22;15:1477550. doi: 10.3389/fphar.2024.1477550. eCollection 2024. Front Pharmacol. 2024. PMID: 39650164 Free PMC article. Review.
Intervention of Compound Xueshuantong Capsule on the incidence of heart failure in patients with acute myocardial infarction after PCI based on the combination of disease and syndrome: A multi-center, randomized, double-blind, controlled trial.
Yang XD, Shi JX, Liao WC, Cui JY, Jin Z, Liu DL, Chen XL, Li R, Wu H, Luo C, Chu Q, Li R, Wu W, Qing L. Yang XD, et al. Among authors: wu h, wu w. Medicine (Baltimore). 2022 Dec 16;101(50):e32311. doi: 10.1097/MD.0000000000032311. Medicine (Baltimore). 2022. PMID: 36550849 Free PMC article. Clinical Trial.
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial.
Shi Y, Guo W, Wang W, Wu Y, Fang M, Huang X, Han P, Zhang Q, Dong P, Zhou X, Peng H, Hu C, Chen X, Zhang S, Chang Z, Li X, Ding Y, Qu S, Jing S, Zhang S, Gui L, Sun Y, Wang L, Liu Y, Wu H, Li G, Fu Z, Shi J, Jiang H, Bai Y, Cui J, Zheng Y, Cui W, Jia X, Zhai L, Cai Q, Xiong D, Wu Y, Cao J, Wu R, Hu G, Peng L, Xie L, Gai W, Wang Y, Su Y. Shi Y, et al. Among authors: wu y, wu h, wu r. Nat Med. 2024 Sep;30(9):2568-2575. doi: 10.1038/s41591-024-03110-7. Epub 2024 Jun 28. Nat Med. 2024. PMID: 38942993 Clinical Trial.
47,386 results
You have reached the last available page of results. Please see the User Guide for more information.